OTC · Household & Personal Products

Kobayashi Pharmaceutical Co., Ltd. (KBYPF) Stock

$34.05 +0.00% OTC: KBYPF Consumer Defensive

Headquartered in Osaka, Japan, and established in 1886, Kobayashi Pharmaceutical Co., Ltd. is a global enterprise specializing in the development, manufacturing, and distribution of a wide array of consumer products.

Valuation

MetricValue
Price$34.05
Market Cap$2.53B
P/E Ratio131.35
P/B Ratio1.93
P/S Ratio2.42
EPS (TTM)$0.26
52-Week High$37.43
52-Week Low$34.05
Dividend Yield2.32%

Financials & Margins

MetricValue
ROE1.46%
ROA1.20%
ROCE6.45%
Gross Margin51.02%
Operating Margin8.24%
Net Margin1.84%
Debt/Equity0.00
Current Ratio3.04

Annual Financials (USD)

Metric20212022202320242025
Revenue$155.3B$166.3B$173.5B$165.6B$165.9B
Operating Profit$26.1B$26.7B$25.8B$24.9B$14.9B
Net Profit$19.7B$20.0B$20.3B$10.1B$3.7B
EPS$252.36$259.59$268.16$135.42$49.19
Op Margin16.8%16.0%14.9%15.0%9.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$252.6B$255.8B$267.5B$265.4B$275.6B
Total Liabilities$57.0B$57.9B$62.7B$51.9B$64.4B
Cash$95.0B$96.2B$71.5B$50.9B$62.4B
Borrowings$630.0M$792.0M$987.0M$846.0M$679.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$22.4B$31.9B$18.4B$11.2B$25.6B
Investing Cash Flow$3.8B$-30.5B$-33.1B$-45.0B$-13.4B
Financing Cash Flow$-4.1B$-14.2B$-12.2B$-263.0M$-268.0M
Net Cash Flow$20.8B$-2.5B$-19.8B$-13.7B$16.5B
Free Cash Flow$18.2B$15.7B$4.8B$-15.4B$12.3B

Valuation & Return Ratios

MetricValue
PEG Ratio-1.84
EV / EBITDA28.05
FCF Yield0.00%
Quick Ratio2.41
Interest Coverage490.71
Return 1Y285.87%
Return 3Y162373.63%
Return 5Y—

Ownership

Insiders Held30.78%
Institutions Held24.91%
Institutions Float Held35.99%
Institutional HolderSharesReport Date
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund735,8012026-04-30
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund494,8042026-03-31
iShares Trust-iShares Core MSCI EAFE ETF365,5002026-06-30
iShares Trust-iShares MSCI EAFE Small-Cap ETF195,1002026-06-30
SCHWAB STRATEGIC TRUST-Schwab International Equity ETF122,2242026-05-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BICEFSociete BIC S.A. $63.60 +0.00% 28.62 $2.59B 4.39%
BLUMYBlue Moon Group Holdings Limited $1.79 +0.00% -50.48 $1.99B 7.26%
KNKZFKWS SAAT SE & Co. KGaA $84.83 +0.00% 15.18 $2.80B 1.72%
KSRYYKOSÉ Corporation $6.75 +0.00% 30.58 $1.92B 2.52%
LIOPFLion Corporation $11.51 +0.00% 16.51 $3.18B 1.91%

About Kobayashi Pharmaceutical Co., Ltd.

Headquartered in Osaka, Japan, and established in 1886, Kobayashi Pharmaceutical Co., Ltd. is a global enterprise specializing in the development, manufacturing, and distribution of a wide array of consumer products. Its extensive offerings span key categories including healthcare, household necessities, skincare, and personal warming items. The company is recognized for a variety of popular brands such as Ammeltz (a topical pain reliever), Inochi no Haha (a women's health remedy), Sarasaty (lingerie soap), and Bluelet Decoral (a toilet cleaner and freshener). Their product lineup further includes Naishitol (a traditional Chinese medicine), Eaude Muge (an anti-acne medicated lotion), dental hygiene items like Itoyoji floss picks and BreathCare capsules, and eye care solutions such as Eyebon eye wash and Netsusama cooling gel sheets. Air fresheners like Sawaday and general deodorizing products, lens cleaners, and other oral hygiene items also form part of their portfolio. Beyond these, the company manufactures pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products. They also market nutritional supplements and skincare directly through online and telephone channels. Complementing its core business, Kobayashi Pharmaceutical is involved in various other activities, including transportation, real estate management, advertising planning and production, and asset management.

Kobayashi Pharmaceutical Co., Ltd. is headquartered in JP.

Kobayashi Pharmaceutical Co., Ltd. (KBYPF) stock trades at $34.05 with a market capitalization of $2.53B. The stock is valued at a price-to-earnings (P/E) ratio of 131.35, price-to-book of 1.93, price-to-sales of 2.42. Over the past 52 weeks the stock has ranged between $34.05 and $37.43, and currently trades 9.0% below its 52-week high. It pays a dividend yielding 2.32%.

On profitability, Kobayashi Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 1.46%, return on capital employed of 6.45%, an operating margin of 8.24%, a net profit margin of 1.84%.

Official website: www.kobayashi.co.jp

Related Consumer Defensive Stocks

WMT Discount Stores $111.85 -0.20% COST Discount Stores $947.82 -0.14% KO Beverages - Non-Alcoholic $87.05 +0.23% PG Household & Personal Products $145.77 -0.82% PM Philip Morris International Inc. $198.44 -0.86% PEP Beverages - Non-Alcoholic $139.02 +0.42% MO Altria Group, Inc. $74.92 +0.13% MNST Beverages - Non-Alcoholic $97.23 -0.52% MDLZ Food Confectioners $64.99 +4.02% CL Household & Personal Products $93.49 +0.82% TGT Discount Stores $145.97 +1.23% DEO Beverages - Wineries & Distilleries $89.16 +0.29%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Consumer Defensive StocksLow P/E Consumer Defensive StocksHigh Net Margin Consumer Defensive StocksDividend Consumer Defensive StocksLow Debt Consumer Defensive StocksAll stock screens
Run Stock Screener Investing Guides